TY - JOUR
T1 - 50 Years of progress in the systemic therapy of non-small cell lung cancer
AU - Wakelee, Heather
AU - Kelly, Karen
AU - Edelman, Martin J.
PY - 2014
Y1 - 2014
N2 - Non-small cell lung cancer constitutes 85% to 90% of lung cancer and is the most common cause of cancer death. Over the past 50 years, substantial progress has been made in all aspects of lung cancer including screening, diagnostic evaluation, surgery, radiation therapy, and chemotherapy. This review focuses on the advances in systemic therapy during this half century.
AB - Non-small cell lung cancer constitutes 85% to 90% of lung cancer and is the most common cause of cancer death. Over the past 50 years, substantial progress has been made in all aspects of lung cancer including screening, diagnostic evaluation, surgery, radiation therapy, and chemotherapy. This review focuses on the advances in systemic therapy during this half century.
UR - http://www.scopus.com/inward/record.url?scp=85003049018&partnerID=8YFLogxK
U2 - 10.14694/EdBook_AM.2014.34.177
DO - 10.14694/EdBook_AM.2014.34.177
M3 - Article
C2 - 24857075
AN - SCOPUS:85003049018
SN - 1548-8756
SP - 177
EP - 189
JO - American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
JF - American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
ER -
